-Review-

SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis

Shijie Mo, Zexuan Su, Baoli Heng, Weijun Chen, Liping Shi, Xinghua Du and Caiyong Lai

Department of Urology, The First Affiliated Hospital, Jinan University, Guangzhou, China

Background/Aim: Epigenetic inactivation of tumor suppressor genes is an important molecular mechanism in the formation and development of human tumors. The purpose of our study was to evaluate the correlation between the methylation level of the secreted frizzled-related protein 1 (SFRP1) gene and the risk of renal cell carcinoma (RCC).
Methods: The relevant literature was searched in detail in several electronic databases. The methodological heterogeneity was analyzed by meta-regression and subgroup analyses. The odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were calculated to summarize the dichotomous outcomes of our meta-analysis.
Results: The ten included articles contained 535 RCC samples and 475 normal controls. The results demonstrated that the methylation level of the SFRP1 promoter region was significantly correlated with an increased incidence of RCC (OR=13.72; 95% CI: 6.01-31.28; P=0.000). Furthermore, the eligible studies that had sufficient clinical data about the RCC cases were included in the analysis, and the results indicated that the frequency of SFRP1 promoter methylation was associated with a higher histological grade (P=0.000), tumor stage (P=0.033), tumor size (≥5 cm; P=0.029), and distant metastasis (P=0.047).
Conclusion: Our results indicate that the methylation level of the SFRP1 promoter region is increased in patients with RCC compared to normal controls and might be involved in the occurrence and development of RCC. Additional well-designed studies are needed to further verify our conclusions.

J Nippon Med Sch 2018; 85: 78-86

Keywords
SFRP1, promoter, methylation, renal cancer, meta-analysis

Correspondence to
Caiyong Lai, Department of Urology, The First Affiliated Hospital, Jinan University, No. 613 West Huangpu Avenue, Guangzhou 510630, Guangdong , China
294037978@qq.com

Received, October 24, 2017
Accepted, January 15, 2018